BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eigentler TK, Leiter U, Häfner H, Garbe C, Röcken M, Breuninger H. Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. Journal of Investigative Dermatology 2017;137:2309-15. [DOI: 10.1016/j.jid.2017.06.025] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Dessinioti C, Platsidaki E, Stratigos AJ. A Sensitivity Meta-Analysis of Disease-Specific Death in Localized Cutaneous Squamous Cell Carcinoma. Dermatology 2022;:1-10. [PMID: 35550380 DOI: 10.1159/000524460] [Reference Citation Analysis]
2 Gee HE, Veness MJ. High-Risk Cutaneous Squamous Cell Carcinoma. Curr Otorhinolaryngol Rep 2018;6:120-8. [DOI: 10.1007/s40136-018-0194-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Tejera-vaquerizo A, García-doval I, Llombart B, Cañueto J, Martorell-calatayud A, Descalzo-gallego MA, Sanmartín O. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma. J Dermatol 2018;45:781-90. [DOI: 10.1111/1346-8138.14342] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
4 Kofler L. [Classification of cutaneous squamous cell carcinoma : How do I recognise my high-risk patient?]. Hautarzt 2019;70:870-4. [PMID: 31560082 DOI: 10.1007/s00105-019-04484-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies R, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2020;18:400-13. [DOI: 10.1111/ddg.14072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
6 Prezzano JC, Scott GA, Lambert Smith F, Mannava KA, Ibrahim SF. Concordance of Squamous Cell Carcinoma Histologic Grading Among Dermatopathologists and Mohs Surgeons. Dermatol Surg 2021;47:1433-7. [PMID: 34482328 DOI: 10.1097/DSS.0000000000003213] [Reference Citation Analysis]
7 Arbab M, Margalit DN, Tishler RB, Rabinowits G, Pashtan IM, Borgelt BB, Powlis W, Holdsworth CH, Warren LE, Schoenfeld JD. Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence. Head Neck 2019;41:2111-5. [PMID: 30697925 DOI: 10.1002/hed.25663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chung E, Hoang S, McEvoy AM, Rosman IS, Hurst EA, Council ML. Histopathologic upgrading of cutaneous squamous cell carcinomas during Mohs micrographic surgery: A retrospective cohort study. J Am Acad Dermatol 2021:S0190-9622(21)00650-2. [PMID: 33812956 DOI: 10.1016/j.jaad.2021.03.086] [Reference Citation Analysis]
9 Totonchy MB, McNiff JM, Suozzi KC, Leffell DJ, Christensen SR. A Histopathologic Scoring System for Perineural Invasion Correlates With Adverse Outcomes in Patients With Cutaneous Squamous Cell Carcinoma. Dermatol Surg 2021;47:445-51. [PMID: 33795563 DOI: 10.1097/DSS.0000000000002923] [Reference Citation Analysis]
10 Hiura A, Yoshino K, Maeda T, Nagai K, Oaku S, Yamashita C, Kato M, Uehara J, Fujisawa Y. Continued Chemotherapy After Concurrent Chemoradiotherapy Improves Treatment Outcomes for Unresectable Cutaneous Squamous Cell Carcinoma: An Analysis of 13 Cases. Front Med (Lausanne) 2019;6:207. [PMID: 31620441 DOI: 10.3389/fmed.2019.00207] [Reference Citation Analysis]
11 Ruiz ES, Koyfman SA, Que SKT, Kass J, Schmults CD. Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins. Journal of the American Academy of Dermatology 2020;82:420-9. [DOI: 10.1016/j.jaad.2019.07.048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Saito Y, Fujikawa H, Takatsuka S, Abe R, Takenouchi T. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients. Int J Clin Oncol 2021;26:606-12. [PMID: 33175299 DOI: 10.1007/s10147-020-01830-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Fine GC, Covington MF, Koppula BR, Salem AE, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology-VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors. Cancers (Basel) 2022;14:2835. [PMID: 35740501 DOI: 10.3390/cancers14122835] [Reference Citation Analysis]
14 Munguía-Calzada P, Fernández-Vega I, Martínez-Camblor P, Díaz-Coto S, García-Pedrero JM, Vivanco B, Osuna CG, Vazquez-Lopez F, Rodrigo JP, Santos-Juanes J. Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma. Head Neck 2019;41:1290-6. [PMID: 30537291 DOI: 10.1002/hed.25556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Hall ET, Fernandez-Lopez E, Silk AW, Dummer R, Bhatia S. Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy. Am Soc Clin Oncol Educ Book 2020;40:1-10. [PMID: 32207669 DOI: 10.1200/EDBK_278953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hillen U, Leiter U, Haase S, Kaufmann R, Becker J, Gutzmer R, Terheyden P, Krause-Bergmann A, Schulze HJ, Hassel J, Lahner N, Wollina U, Ziller F, Utikal J, Hafner C, Ulrich J, Machens HG, Weishaupt C, Hauschild A, Mohr P, Pföhler C, Maurer J, Wolff P, Windemuth-Kieselbach C, Schadendorf D, Livingstone E; Dermatologic Cooperative Oncology Group (DeCOG). Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG. Eur J Cancer 2018;96:34-43. [PMID: 29665511 DOI: 10.1016/j.ejca.2018.01.075] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
17 Dessinioti C, Pitoulias M, Stratigos AJ. Epidemiology of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2021. [PMID: 34592000 DOI: 10.1111/jdv.17709] [Reference Citation Analysis]
18 Gao SJ, Decker RH. Contemporary Topics in Radiation Medicine: Skin Cancer. Hematol Oncol Clin North Am 2020;34:189-203. [PMID: 31739944 DOI: 10.1016/j.hoc.2019.09.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Fujimoto M, Yamamoto Y, Takai T, Fujimoto N, Ogawa K, Yoshikawa T, Matsuzaki I, Takahashi Y, Iwahashi Y, Warigaya K, Kojima F, Jinnin M, Murata S. Tumor Budding Is an Objective High-risk Factor Associated With Metastasis and Poor Clinical Prognosis in Cutaneous Squamous Cell Carcinoma Sized <4 cm. American Journal of Surgical Pathology 2019;43:975-83. [DOI: 10.1097/pas.0000000000001284] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Bossi P. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Eur J Cancer 2021;157:250-8. [PMID: 34536948 DOI: 10.1016/j.ejca.2021.08.018] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Dallari S, Zaraca G, Giorgini S, Borgonzoni M. Close and positive margins in non-melanoma skin malignancies of the head and neck. What to do in patients over 75 years of age? A preliminary study. G Ital Dermatol Venereol 2020;155:464-9. [PMID: 29963799 DOI: 10.23736/S0392-0488.18.05853-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Zambrano-Román M, Padilla-Gutiérrez JR, Valle Y, Muñoz-Valle JF, Valdés-Alvarado E. Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives. Cancers (Basel) 2022;14:2371. [PMID: 35625975 DOI: 10.3390/cancers14102371] [Reference Citation Analysis]
23 Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Fargnoli MC, Forsea AM, Frenard C, Harwood CΑ, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer 2020;128:60-82. [PMID: 32113941 DOI: 10.1016/j.ejca.2020.01.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
24 de Jong E, Lammerts MUPA, Genders RE, Bouwes Bavinck JN. Update of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2022;36 Suppl 1:6-10. [PMID: 34855246 DOI: 10.1111/jdv.17728] [Reference Citation Analysis]
25 Bander TS, Nehal KS, Lee EH. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management. Dermatol Clin 2019;37:241-51. [PMID: 31084718 DOI: 10.1016/j.det.2019.03.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
26 Pêtre A, Pommier P, Brahmi T, Chabaud S, King S, Fayette J, Neidhart E, Amini-adle M. Benefit from adjuvant radiotherapy according to the number of risk factors in cutaneous squamous cell carcinoma. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.01.015] [Reference Citation Analysis]
27 Amaral T, Osewold M, Presser D, Meiwes A, Garbe C, Leiter U. Advanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patterns. J Eur Acad Dermatol Venereol 2019;33 Suppl 8:44-51. [PMID: 31658392 DOI: 10.1111/jdv.15845] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
28 Wu S, Slater NA, Sayed CJ, Googe PB. PD‐L1 and LAG ‐3 expression in advanced cutaneous squamous cell carcinomas. J Cutan Pathol 2020;47:882-7. [DOI: 10.1111/cup.13709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ruiz ES, Karia PS, Besaw R, Schmults CD. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma. JAMA Dermatol 2019;155:819-25. [PMID: 30969315 DOI: 10.1001/jamadermatol.2019.0032] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
30 Leiter U. What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma? Br J Dermatol 2021;184:384-5. [PMID: 33666952 DOI: 10.1111/bjd.19861] [Reference Citation Analysis]
31 Rabinowits G, Migden MR, Schlesinger TE, Ferris RL, Freeman M, Guild V, Koyfman S, Pavlick AC, Swanson N, Wolf GT, Dinehart SM. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. JID Innov 2021;1:100045. [PMID: 34909742 DOI: 10.1016/j.xjidi.2021.100045] [Reference Citation Analysis]
32 Lorenzo-Martín LF, Fernández-Parejo N, Menacho-Márquez M, Rodríguez-Fdez S, Robles-Valero J, Zumalave S, Fabbiano S, Pascual G, García-Pedrero JM, Abad A, García-Macías MC, González N, Lorenzano-Menna P, Pavón MA, González-Sarmiento R, Segrelles C, Paramio JM, Tubío JMC, Rodrigo JP, Benitah SA, Cuadrado M, Bustelo XR. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma. Nat Commun 2020;11:4788. [PMID: 32963234 DOI: 10.1038/s41467-020-18524-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C. S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit. J Dtsch Dermatol Ges 2020;18:400-13. [PMID: 32291932 DOI: 10.1111/ddg.14072_g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Stanganelli I, Spagnolo F, Argenziano G, Ascierto PA, Bassetto F, Bossi P, Donato V, Massi D, Massone C, Patuzzo R, Pellacani G, Quaglino P, Queirolo P, Zalaudek I, Palmieri G; on behalf of Italian Melanoma Intergroup (IMI). The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts. Cancers 2022;14:377. [DOI: 10.3390/cancers14020377] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Tschetter AJ, Campoli MR, Zitelli JA, Brodland DG. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study. Journal of the American Academy of Dermatology 2020;82:139-48. [DOI: 10.1016/j.jaad.2019.06.1303] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
36 Willcox JL, Marks SL, Ueda Y, Skorupski KA. Clinical features and outcome of dermal squamous cell carcinoma in 193 dogs (1987-2017). Vet Comp Oncol 2019;17:130-8. [PMID: 30684311 DOI: 10.1111/vco.12461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
37 Zeng S, Fu L, Zhou P, Ling H. Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis. PLoS One 2020;15:e0239586. [PMID: 32991600 DOI: 10.1371/journal.pone.0239586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Haug K, Breuninger H, Metzler G, Eigentler T, Eichner M, Häfner HM, Schnabl SM. Prognostic Impact of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Results of a Prospective Study of 1,399 Tumors. J Invest Dermatol 2020;140:1968-75. [PMID: 32169476 DOI: 10.1016/j.jid.2020.01.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
39 Lubov J, Labbé M, Sioufi K, Morand GB, Hier MP, Khanna M, Sultanem K, Mlynarek AM. Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review. J Otolaryngol Head Neck Surg 2021;50:54. [PMID: 34493343 DOI: 10.1186/s40463-021-00529-7] [Reference Citation Analysis]
40 Bacorn C, Kim E, Lin LK. Eyelid abscess masking underlying sebaceous cell carcinoma. Orbit 2020;39:212-6. [PMID: 31530211 DOI: 10.1080/01676830.2019.1663885] [Reference Citation Analysis]
41 Farberg AS, Fitzgerald AL, Ibrahim SF, Tolkachjov SN, Soleymani T, Douglas LM, Kurley SJ, Arron ST. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review. Dermatol Ther (Heidelb) 2022. [PMID: 34994967 DOI: 10.1007/s13555-021-00673-y] [Reference Citation Analysis]
42 Rosenberg AR, Tabacchi M, Ngo KH, Wallendorf M, Rosman IS, Cornelius LA, Demehri S. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention. JCI Insight 2019;4:125476. [PMID: 30895944 DOI: 10.1172/jci.insight.125476] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
43 Breuninger H, Eigentler T, Häfner HM, Leiter U. Local surgical treatment of cutaneous squamous cell carcinoma: deficits and controversies in the literature. J Dtsch Dermatol Ges 2019;17:999-1004. [PMID: 31545559 DOI: 10.1111/ddg.13941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Ishitsuka Y, Hanaoka Y, Tanemura A, Fujimoto M. Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy. Cancers (Basel) 2021;13:1148. [PMID: 33800195 DOI: 10.3390/cancers13051148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Froch-cortis J, Fries J, Rothschild MA. Das „explodierte Karbunkel“: Selbstbestimmte Therapieverweigerung bis in den Tod. Rechtsmedizin 2019;29:493-7. [DOI: 10.1007/s00194-019-00355-2] [Reference Citation Analysis]
46 Guida M, Quaglino P, Queirolo P. Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers. Front Oncol 2022;12:870509. [PMID: 35664785 DOI: 10.3389/fonc.2022.870509] [Reference Citation Analysis]
47 Santos-Juanes J, Fernández-Vega I, Lorenzo-Herrero S, Sordo-Bahamonde C, Martínez-Camblor P, García-Pedrero JM, Vivanco B, Galache-Osuna C, Vazquez-Lopez F, Gonzalez S, Rodrigo JP. Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma. Arch Dermatol Res 2019;311:369-76. [PMID: 30955082 DOI: 10.1007/s00403-019-01916-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
48 Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS, Buzurovic I, Geiger JL, Parvathaneni U, Zaky S, Devlin PM. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol 2020;10:8-20. [PMID: 31831330 DOI: 10.1016/j.prro.2019.10.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
49 Weinhammer A, Bennett DD, Longley JB, Eickhoff J, Xu YG. Precise measurement of cutaneous squamous cell carcinoma thickness. J Am Acad Dermatol 2021:S0190-9622(21)02560-3. [PMID: 34600956 DOI: 10.1016/j.jaad.2021.09.049] [Reference Citation Analysis]
50 Christensen SR. Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas. F1000Res 2018;7:F1000 Faculty Rev-690. [PMID: 29904586 DOI: 10.12688/f1000research.12837.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
51 Keohane SG, Botting J, Budny PG, Dolan OM, Fife K, Harwood CA, Mallipeddi R, Marsden JR, Motley RJ, Newlands C, Proby C, Rembielak A, Slater DN, Smithson JA, Buckley P, Fairbrother P, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol 2021;184:401-14. [PMID: 33150585 DOI: 10.1111/bjd.19621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
52 Lee CT, Lehrer EJ, Aphale A, Lango M, Galloway TJ, Zaorsky NG. Surgical excision, Mohs micrographic surgery, external‐beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta‐analysis of 58 studies with 21,000 patients. Cancer 2019;125:3582-94. [DOI: 10.1002/cncr.32371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
53 Warnig C, Wollina U. Cutaneous squamous cell carcinoma of head and neck region: A single center analysis of 1296 tumors with clinical characteristics, comorbidities, treatment, and sun-protection behavior. Dermatol Ther 2021;34:e14992. [PMID: 34009659 DOI: 10.1111/dth.14992] [Reference Citation Analysis]
54 Ruiz ES. Radiologic Imaging for High-Stage Cutaneous Squamous Cell Carcinomas. JAMA Dermatol 2021. [PMID: 34964808 DOI: 10.1001/jamadermatol.2021.4989] [Reference Citation Analysis]
55 Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. Cancer 2020;126:3900-6. [PMID: 32478867 DOI: 10.1002/cncr.32969] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
56 Gupta N, Weitzman RE, Murad F, Koyfman SA, Smile TD, Chang MS, Maher JM, Schmults CD, Vidimos AT, Ruiz ES. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes. J Am Acad Dermatol 2021:S0190-9622(21)02918-2. [PMID: 34864111 DOI: 10.1016/j.jaad.2021.11.046] [Reference Citation Analysis]
57 Puebla-Tornero L, Corchete-Sánchez LA, Conde-Ferreirós A, García-Sancha N, Corchado-Cobos R, Román-Curto C, Cañueto J. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2021;84:938-45. [PMID: 33333151 DOI: 10.1016/j.jaad.2020.12.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Aleman JD, Young CD, Karam SD, Wang XJ. Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research? Mol Carcinog 2022. [PMID: 35596706 DOI: 10.1002/mc.23417] [Reference Citation Analysis]
59 Hruza GJ, Billingsley EM, Brown MD, Storrs PA. In Regard to the American Society for Radiation Oncology Clinical Practice Guidelines on Radiation Therapy for Basal and Squamous Cell Cancers of the Skin. Pract Radiat Oncol 2020;10:209-10. [PMID: 32035247 DOI: 10.1016/j.prro.2020.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Brancaccio G, Briatico G, Pellegrini C, Rocco T, Moscarella E, Fargnoli MC. Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma. Dermatol Pract Concept 2021;11:e2021166S. [PMID: 34877074 DOI: 10.5826/dpc.11S2a166S] [Reference Citation Analysis]
61 Tejera-Vaquerizo A, Cañueto J, Llombart B, Martorell-Calatayud A, Sanmartín O. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria. Dermatol Surg 2020;46:857-62. [PMID: 31567487 DOI: 10.1097/DSS.0000000000002170] [Reference Citation Analysis]